India may lose Rs 6,300 Crores in pharma exports
Advertisement
Advertisement
India is set to suffer at least $1 billion (Rs 6,300 crore) of losses in pharmaceutical exports this fiscal year after the European Commission banned nearly 700 generic drugs after GVK Bio allegedly manipulated clinical trials.Director general of Pharmaceuticals Export Promotion Council PV Appaji said, "Majority of those 700 generic drugs are either produced or sourced by the domestic and multinational
A
Appaji said that the commerce ministry is scheduled to organize discussions with the stakeholders in the next couple of days and may lodge a compliant with the global agencies against the
India reportedly exported $15.2 billion or Rs 94,275 crore of pharmaceutical products in 2014-15, with European Union accounting for a fifth or $3 billion.
Advertisement
Image credit: Indiatimes
Advertisement
- US buys 81 Soviet-era combat aircraft from Russia's ally costing on average less than $20,000 each, report says
- 2 states where home prices are falling because there are too many houses and not enough buyers
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- Foreign tourist arrivals in India will cross pre-pandemic level in 2024
- Upcoming smartphones launching in India in May 2024
- Markets rebound in early trade amid global rally, buying in ICICI Bank and Reliance
- Women in Leadership
- Rupee declines 5 paise to 83.43 against US dollar in early trade
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market